Marta Pestrin

1.8k total citations
42 papers, 1.2k citations indexed

About

Marta Pestrin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marta Pestrin has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 27 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marta Pestrin's work include Cancer Genomics and Diagnostics (15 papers), HER2/EGFR in Cancer Research (13 papers) and Advanced Breast Cancer Therapies (12 papers). Marta Pestrin is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), HER2/EGFR in Cancer Research (13 papers) and Advanced Breast Cancer Therapies (12 papers). Marta Pestrin collaborates with scholars based in Italy, Belgium and United States. Marta Pestrin's co-authors include Angelo Di Leo, Laura Biganzoli, Francesca Galardi, Wederson M. Claudino, Silvia Bessi, Francesca De Luca, Alessandro Quattrone, Ivano Bertini, Francesca Salvianti and Luca Malorni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marta Pestrin

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Pestrin Italy 16 860 712 405 324 127 42 1.2k
Jiangdong Qiu China 14 525 0.6× 489 0.7× 580 1.4× 150 0.5× 113 0.9× 22 1.2k
Alexios Matikas Sweden 19 929 1.1× 413 0.6× 395 1.0× 370 1.1× 48 0.4× 92 1.4k
Michaela J. Higgins United States 18 530 0.6× 413 0.6× 680 1.7× 246 0.8× 56 0.4× 60 1.3k
Eugen Ruckhaeberle Germany 15 863 1.0× 705 1.0× 348 0.9× 223 0.7× 67 0.5× 20 1.5k
Monika Bauden Sweden 18 634 0.7× 306 0.4× 523 1.3× 172 0.5× 51 0.4× 32 1.1k
Edik M. Blais United States 16 681 0.8× 499 0.7× 378 0.9× 180 0.6× 121 1.0× 34 1.1k
Min Kyung Ju South Korea 12 365 0.4× 469 0.7× 691 1.7× 136 0.4× 84 0.7× 16 1.1k
Yuxi Zhu China 17 304 0.4× 479 0.7× 492 1.2× 197 0.6× 99 0.8× 45 965
Jean‐Claude Cutz Canada 20 403 0.5× 319 0.4× 666 1.6× 370 1.1× 29 0.2× 45 1.1k

Countries citing papers authored by Marta Pestrin

Since Specialization
Citations

This map shows the geographic impact of Marta Pestrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Pestrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Pestrin more than expected).

Fields of papers citing papers by Marta Pestrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Pestrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Pestrin. The network helps show where Marta Pestrin may publish in the future.

Co-authorship network of co-authors of Marta Pestrin

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Pestrin. A scholar is included among the top collaborators of Marta Pestrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Pestrin. Marta Pestrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardone, Agostina, Nicola Casiraghi, Francesca Galardi, et al.. (2025). Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer. npj Breast Cancer. 11(1). 25–25. 2 indexed citations
2.
Romagnoli, Dario, Agostina Nardone, Francesca Galardi, et al.. (2023). MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples. Briefings in Bioinformatics. 24(2). 1 indexed citations
3.
Benelli, Matteo, Antonio Nardone, Francesca Galardi, et al.. (2023). 2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast cancer (mBC). Annals of Oncology. 34. S1166–S1166. 1 indexed citations
4.
Sanna, Giuseppina, Marta Pestrin, Erica Moretti, et al.. (2020). A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer. Clinical Breast Cancer. 21(4). e332–e339. 3 indexed citations
5.
Rossi, Lorenzo, Chiara Biagioni, Amelia McCartney, et al.. (2019). Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial. Breast Cancer Research. 21(1). 71–71. 20 indexed citations
6.
7.
Rossi, Lorenzo, Chiara Biagioni, Amelia McCartney, et al.. (2018). Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature. Anticancer Research. 38(8). 4839–4845. 7 indexed citations
8.
Pestrin, Marta, Francesca Salvianti, Francesca Galardi, et al.. (2014). Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Molecular Oncology. 9(4). 749–757. 135 indexed citations
9.
Turner, Natalie, Laura Biganzoli, Luca Malorni, et al.. (2013). Adjuvant Chemotherapy: Which Patient? What Regimen?. American Society of Clinical Oncology Educational Book. 3–8. 2 indexed citations
10.
Pestrin, Marta, Francesca Galardi, Francesca Salvianti, et al.. (2013). Molecular Analysis of Single Circulating Tumor Cells (CTCS) Isolated from Metastatic Breast Cancer (MBC) Patients (PTS). Annals of Oncology. 24. iii29–iii29. 2 indexed citations
11.
Stebbing, Justin, Rachel Payne, J.A. Reise, et al.. (2013). The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study. PLoS ONE. 8(5). e62543–e62543. 24 indexed citations
12.
Turner, Natalie, Laura Biganzoli, Luca Malorni, et al.. (2013). The continued evidence from overviews: What is the clinical utility?. The Breast. 22. S8–S11. 1 indexed citations
13.
Ignatiadis, Michail, Françoise Rothé, Carole Chaboteaux, et al.. (2011). HER2-Positive Circulating Tumor Cells in Breast Cancer. PLoS ONE. 6(1). e15624–e15624. 159 indexed citations
14.
Oakman, Catherine, Anna Sapino, Caterina Marchiò, et al.. (2010). Chemotherapy with or without trastuzumab. Annals of Oncology. 21. vii112–vii119. 7 indexed citations
15.
Oakman, Catherine, et al.. (2009). Adjuvant chemotherapy – the dark side of clinical trials Have we learnt more?. The Breast. 18. S18–S24. 3 indexed citations
16.
Pestrin, Marta, Silvia Bessi, Francesca Galardi, et al.. (2009). Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Research and Treatment. 118(3). 523–530. 169 indexed citations
17.
Biganzoli, Laura, et al.. (2008). Taxanes in the elderly: Can we gain as much and be less toxic?. Critical Reviews in Oncology/Hematology. 70(3). 262–271. 13 indexed citations
18.
Minisini, Alessandro Marco, Dora Fabbro, Carla Di Loreto, et al.. (2007). Markers of the uPA System and Common Prognostic Factors in Breast Cancer. American Journal of Clinical Pathology. 128(1). 112–117. 17 indexed citations
19.
Leo, Angelo Di, Wederson M. Claudino, Donato Colangiuli, et al.. (2007). New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer. Annals of Oncology. 18. xii8–xii14. 23 indexed citations
20.
Biganzoli, Laura, Wederson M. Claudino, Marta Pestrin, Daniele Pozzessere, & Angelo Di Leo. (2007). Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: Where do we stand?. Critical Reviews in Oncology/Hematology. 62(1). 1–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiangdong Qiu Breakdown of academic impact, for papers by Alexios Matikas Breakdown of academic impact, for papers by Michaela J. Higgins Breakdown of academic impact, for papers by Eugen Ruckhaeberle Breakdown of academic impact, for papers by Monika Bauden Breakdown of academic impact, for papers by Edik M. Blais Breakdown of academic impact, for papers by Min Kyung Ju Breakdown of academic impact, for papers by Yuxi Zhu Breakdown of academic impact, for papers by Jean‐Claude Cutz
Rankless by CCL
2026